One of the possible explanations of these conflicting results may be different sTILs cut-off points: for MA.31, TILs > 5% were considered high, while CLEOPATRA used the cut-off point of 20%; thus further research is needed on optimal TILs cut-off for metastatic HER2+ BC (Figure 2). This evidence concerns the gene ERBB2 and breast cancer.